Continuation Rates and Satisfaction with the Levonorgestrel Intrauterine Device in Nulliparous Adolescents Undergoing Bariatric Surgery
Kanj, R V.; Schwartz, B I.; Alexander, M; Barth, J F.; Hoefgen, H R.; Trotman, G E.; Breech, L L.
Journal of Pediatric and Adolescent Gynecology 29(2): 203-204
2016
ISSN/ISBN: 1083-3188 DOI: 10.1016/j.jpag.2016.01.103Document Number: 220214
Document emailed within 0-6 h
Related Documents
Akintomide, H.; James, A.; Moffat, M.; Barnes, P.; Rankin, J. 2022: Systematic review of copper intrauterine contraception continuation in young nulliparous women based on intrauterine device type Bmj Open 12(10): E060606Akintomide, H.; James, A.; Moffat, M.; Barnes, P.; Rankin, J. 2022: Systematic review of copper intrauterine contraception continuation in young nulliparous women based on intrauterine device type Bmj Open 12(10): E060606
Vaitsiakhovich, T.; Filonenko, A.; Lynen, R.; Endrikat, J.; Gerlinger, C. 2018: Cross design analysis of randomized and observational data - application to continuation rates for a contraceptive intra uterine device containing Levonorgestrel in adolescents and adults Bmc Women's Health 18(1): 180
McNicholas, C.; Hotchkiss, T.; Madden, T.; Zhao, Q.; Allsworth, J.; Peipert, J.F. 2012: Immediate postabortion intrauterine device insertion: continuation and satisfaction Women's Health Issues: Official Publication of the Jacobs Institute of Women's Health 22(4): E365-E369
Weisberg, E.; Bateson, D.; McGeechan, K.; Mohapatra, L. 2014: A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 19(1): 5-14
Munteanu, O.; Cirstoiu, M.; Antoniac, I.; Cirstoiu, C. 2016: Comparison of Pain Level During and After Intrauterine Device Insertion: Levonorgestrel-Releasing Intrauterine System Versus the Copper T Intrauterine Device Environmental Engineering and Management Journal 15(5): 965-972
Savasi, I.; Jayasinghe, K.; Moore, P.; Jayasinghe, Y.; Grover, S.R. 2014: Complication rates associated with levonorgestrel intrauterine system use in adolescents with developmental disabilities Journal of Pediatric and Adolescent Gynecology 27(1): 25-28
Paterson, H.; Miller, D.; Devenish, C. 2009: A survey of New Zealand RANZCOG Fellows on their use of the levonorgestrel intrauterine device in adolescents Australian and New Zealand Journal of Obstetrics and Gynaecology 49(2): 220-225
Abou-Setta, A.M.; Houston, B.; Al-Inany, H.G.; Farquhar, C. 2013: Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery Cochrane Database of Systematic Reviews 1: Cd005072
Suhonen, S.; Haukkamaa, M.; Jakobsson, T.; Rauramo, I. 2004: Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study Contraception 69(5): 407-412
Bastianelli, C.; Farris, M.; Lippa, A.; Lucantoni, V.; Valente, A. 1998: Use of intrauterine device by nulliparous women. Prospective study and preliminary data Minerva Ginecologica 50(6): 231-233
Bilgehan, F.; Dilbaz, B.; Karadag, B.; Deveci, C.D. 2015: Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception Journal of Obstetrics and Gynaecology Research 41(9): 1426-1432
Bosco-Lévy, P.; Gouverneur, A.; Langlade, C.; Miremont, G.; Pariente, A. 2019: Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study Contraception 99(6): 345-349
Espey, E.; Singh, R.H.; Leeman, L.; Ogburn, T.; Fowler, K.; Greene, H. 2014: Misoprostol for intrauterine device insertion in nulliparous women: a randomized controlled trial American Journal of Obstetrics and Gynecology 210(3): 208.E1-5
Edelman, A.B.; Schaefer, E.; Olson, A.; Van Houten, L.; Bednarek, P.; Leclair, C.; Jensen, J.T. 2011: Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women Contraception 84(3): 234-239
Swenson, C.; Turok, D.K.; Ward, K.; Jacobson, J.C.; Dermish, A. 2012: Self-administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial Obstetrics and Gynecology 120(2 Part 1): 341-347
Lathrop, E.; Haddad, L.; McWhorter, C.P.; Goedken, P. 2013: Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial Contraception 88(6): 725-729
Ng, Y.W.; Liang, S.; Singh, K. 2009: Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study Contraception 79(1): 24-28
Berenson, A.B.; Tan, A.; Hirth, J.M.; Wilkinson, G.S. 2013: Complications and continuation of intrauterine device use among commercially insured teenagers Obstetrics and Gynecology 121(5): 951-958
Thiery, M.; Van der Pas, H.; Delbarge, W.; Van Kets, H. 1989: The levonorgestrel intrauterine device Geburtshilfe und Frauenheilkunde 49(2): 186-188